Metformin enhances anti-tumor effect of L-type amino acid transporter 1 (LAT1) inhibitor
Background: In many cancer cells, L-type amino acid transporter 1 (LAT1) transports neutral amino acids with bulky side chain, which activate mammalian target of rapamycin (mTOR) to cause cell proliferation. An anti-diabetic drug, metformin, has been shown to activate AMP-activated protein kinase (A...
Saved in:
Main Authors: | Seiji Ueno (Author), Toru Kimura (Author), Takashi Yamaga (Author), Akihiko Kawada (Author), Toshiaki Ochiai (Author), Hitoshi Endou (Author), Hiroyuki Sakurai (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LAT1 Is a Central Transporter of Essential Amino Acids in Human Umbilical Vein Endothelial Cells
by: Keitaro Hayashi, et al.
Published: (2014) -
LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells
by: Keitaro Hayashi, et al.
Published: (2016) -
Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1)
by: Pornparn Kongpracha, et al.
Published: (2017) -
Establishment of Stable Cell Lines With High Expression of Heterodimers of Human 4F2hc and Human Amino Acid Transporter LAT1 or LAT2 and Delineation of Their Differential Interaction With α-Alkyl Moieties
by: Narakorn Khunweeraphong, et al.
Published: (2012) -
Aminopeptidase B can bioconvert L-type amino acid transporter 1 (LAT1)-utilizing amide prodrugs in the brain
by: Agathe Hugele, et al.
Published: (2022)